Skip to main content
Top

SCORE2-diabetes for predicting coronary artery disease: a cardiac CT study in a diabetic moderate-risk region population

Published in:

Abstract

Background

Current approaches to estimating the probability of coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM) often fail to reflect the clinical complexity of the condition, as they tend to oversimplify it by neglecting its progressive nature, variability in glycemic control, and the influence of disease duration. The SCORE2-Diabetes (SCORE2-D) model was developed to offer a more nuanced cardiovascular risk estimate by incorporating continuous variables and individualized risk factor weighting. However, its correlation with the actual presence and severity of CAD in diabetic patients remains under-investigated.

Objective

This study aims to evaluate the association between SCORE2-D scores and CAD characteristics, as assessed by computed tomography coronary angiography (CCTA), in patients with T2DM and no prior coronary revascularization. Specifically, it investigates the relationship between SCORE2-D risk categories and the presence, morphology, and severity of coronary plaques.

Methods

A retrospective analysis was conducted on patients aged 40–69 with T2DM, no history of atherosclerotic cardiovascular disease, and no severe target organ damage, who underwent CCTA at a tertiary care center. Clinical data, SCORE2-D values, and imaging results were collected. Patients were stratified into SCORE2-D risk categories, and coronary findings were compared across groups.

Results

The study included 104 patients (mean age 60.9 years; mean SCORE2-D 12.2 ± 4.9). Higher SCORE2-D scores were significantly associated with the presence of coronary plaques. In the low–moderate risk group, calcified and non-calcified plaques were similarly distributed, while in the high–very high risk group, non-calcified (lipid-rich and mixed) plaques predominated, indicating potentially more vulnerable lesions. Proximal coronary segments, especially the left anterior descending artery, were most frequently involved. A progressive increase in plaque burden and stenosis severity was observed with rising SCORE2-D risk category. Patients at higher risk were more often referred for invasive coronary angiography.

Conclusions

Higher SCORE2-D scores correlate with greater CAD burden, more severe stenosis, and a predominance of high-risk plaque features in patients with T2DM. These findings suggest that SCORE2-D may be a valuable tool in refining cardiovascular risk stratification and guiding clinical decision-making in diabetic populations.

Graphical abstract

Title
SCORE2-diabetes for predicting coronary artery disease: a cardiac CT study in a diabetic moderate-risk region population
Authors
Rocco Mollace
Matteo Nardin
Matteo Arzenton
Federica Testerini
Anita Fumagalli
Flavia Nicoli
Margherita Celeste Licastro
Alessandro Nudi
Valentina Bernardini
Federica Frascaro
Silvana Di Maio
Rossella Menghini
Elona Collaku
Giorgio Agati
Eleonora Corghi
Maria Lo Monaco
Davide Cao
Antonio Cardamone
Cristina Carresi
Anna Rita Coppoletta
Eugenio Martelli
Gianluca Campo
Giulio Stefanini
Erika Bertella
Massimo Federici
Publication date
01-12-2025
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2025
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-025-03000-3
This content is only visible if you are logged in and have the appropriate permissions.
This content is only visible if you are logged in and have the appropriate permissions.

Keynote webinar | Spotlight on progress in colorectal cancer

CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.

Prof. Antoni Castells
Prof. Harpreet Wasan
Prof. Edward Giovannucci
Watch now

Keynote webinar | Spotlight on functional neurological disorder

FND perplexes and frustrates patients and physicians alike. Limited knowledge and insufficient awareness delays diagnosis and treatment, and many patients feel misunderstood and stigmatized. How can you recognize FND and what are the treatment options?

Prof. Mark Edwards
Watch now
Video
Image Credits
Colon cancer illustration/© (M) KATERYNA KON / SCIENCE PHOTO LIBRARY / Getty Images, Human brain illustration/© (M) CHRISTOPH BURGSTEDT / SCIENCE PHOTO LIBRARY / Getty Images